Institute of Digitalization in Medicine, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany
Institute of Medical Biometry and Statistics, Department of Methods in Clinical Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
J Neurointerv Surg. 2024 Mar 14;16(4):365-371. doi: 10.1136/jnis-2023-020181.
Evidence on clinical outcome after endovascular treatment (EVT) vs neurosurgical clipping of intracranial aneurysms (IAs) is based on one randomized and one pseudo-randomized trial for ruptured aneurysms. Herein, we analyze nationwide real-world hospital outcomes after EVT vs clipping of ruptured and unruptured IAs.
This cohort study analyzed all EVT and clipping procedures for IAs in Germany between 2007 and 2019. The data basis was the billing-data of all German hospitals from the German Federal Statistical Office. EVT and clipping interventions, comorbidities, and in-hospital outcomes were identified using International Classification of Diseases (ICD) and Operation and Procedure (OPS) codes. Discharge type was used as a surrogate marker for functional independence. Poor clinical outcome at discharge was additionally defined by the dichotomous US National Inpatient Sample-Subarachnoid hemorrhage Outcome Measure score (NIH-SOM). Secondary outcomes included length of hospital stay, prolonged mechanical ventilation (>48 hour), and hospital reimbursement.
We analyzed 90 039 procedures (62.6% EVT, 35.52% clipping, 1.8% combined) for the treatment of IAs. After adjustment in-hospital mortality was equal after EVT compared with clipping, in ruptured IAs (adjusted OR (aOR) 0.98, p=0.707) and unruptured IAs (aOR 0.92, p=0.482). Functional independence was more likely after EVT for ruptured (aOR 0.81, p<0.001) and unruptured IAs (aOR 0.4, p<0.001). Poor clinical outcome was more likely after clipping for ruptured (aOR 0.67, p<0.001) and unruptured IAs (aOR 0.56, p<0.001).
In German clinical practice, we observed higher rates of functional independence and lower rates of poor outcomes at discharge with equal mortality for EVT.
血管内治疗 (EVT) 与开颅夹闭治疗颅内动脉瘤 (IA) 的临床结局证据基于一项破裂动脉瘤的随机和一项假随机试验。在此,我们分析了德国全国范围内 EVT 与破裂和未破裂 IA 开颅夹闭的真实世界医院结局。
本队列研究分析了德国 2007 年至 2019 年间所有的 EVT 和夹闭治疗 IA 的病例。数据基础是德国联邦统计局所有德国医院的计费数据。使用国际疾病分类 (ICD) 和操作和程序 (OPS) 代码识别 EVT 和夹闭干预、合并症和住院结局。出院类型被用作功能独立的替代标志物。出院时的不良临床结局还通过美国国立住院患者样本蛛网膜下腔出血结局测量评分(NIH-SOM)的二分类来定义。次要结局包括住院时间延长、机械通气延长 (>48 小时) 和医院报销。
我们分析了 90039 例 IA 治疗的手术(62.6%EVT、35.52%夹闭、1.8%联合)。调整后,EVT 组与夹闭组的住院死亡率相当,在破裂 IA 中(校正比值比 (aOR) 0.98,p=0.707)和未破裂 IA 中(aOR 0.92,p=0.482)。EVT 组更可能实现破裂 (aOR 0.81,p<0.001) 和未破裂 IA 患者的功能独立 (aOR 0.4,p<0.001)。对于破裂和未破裂 IA,夹闭组的不良临床结局发生率更高(破裂 aOR 0.67,p<0.001;未破裂 aOR 0.56,p<0.001)。
在德国的临床实践中,EVT 组的功能独立性更高,出院时不良结局的发生率更低,死亡率相当。